This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Astrazeneca Ab. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Alla Pryyma
Introduction
Alla Pryyma is a notable inventor based in Waltham, MA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of conjugates that have potential applications in cancer treatment. Her work exemplifies the intersection of innovation and healthcare, showcasing how inventions can lead to advancements in medical therapies.
Latest Patents
Alla Pryyma holds a patent for "Conjugates comprising cleavable beta-glucuronide-containing linkers." This patent relates to conjugates that include a linker of Formula (IA) and pharmaceutically acceptable salts thereof. The specification details the use of these conjugates for treating diseases such as cancer, along with intermediates that are useful for synthesizing these conjugates. This patent highlights her innovative approach to addressing complex medical challenges.
Career Highlights
Throughout her career, Alla Pryyma has focused on developing novel therapeutic solutions. Her work has not only contributed to scientific knowledge but has also paved the way for new treatment options in oncology. With her expertise, she has positioned herself as a key figure in pharmaceutical innovation.
Collaborations
Alla has collaborated with esteemed colleagues, including Akbar Husain Khan and Andreas Lothar Severino Maderna. These partnerships have enhanced her research and contributed to the successful development of her patented technologies.
Conclusion
Alla Pryyma's contributions to the field of pharmaceuticals through her innovative patents demonstrate the vital role of inventors in advancing medical science. Her work continues to inspire future innovations in cancer treatment and beyond.